Heron Bay Capital Management Amgen Inc Transaction History

Heron Bay Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $966,103 - $1.07 Million	-4,406 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $243,230 - $278,354	-1,223 Reduced 21.73%	4,406 $991,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $156,655 - $183,540	738 Added 15.09%	5,629 $1.2 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $1.53 Million - $1.7 Million	-6,544 Reduced 57.23%	4,891 $1.19 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $98,749 - $115,077	445 Added 4.05%	11,435 $2.85 Million

Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $2.38 Million - $2.83 Million	10,990 New	10,990 $2.53 Million

2,930

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

Stay updated on Heron Bay Capital Management with notifications on news.